
Vera A Bittner MD
Nuclear Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation, Cardiac Critical Care
Professor, Medicine, University of Alabama School of Medicine
Join to View Full Profile
2000 6th Ave SBirmingham, AL 35233
Phone+1 205-934-9999
Dr. Bittner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Section Head, Preventive Cardiology
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Cardiovascular Disease, 1984 - 1987
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1981 - 1984
University of South Alabama College of MedicineClass of 1981
Certifications & Licensure
AL State Medical License 1984 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- Persistent chest pain trends at 3 years in women with INOCA vs. obstructive CAD: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).Okezi Obrutu, Martha Gulati, Steven Reis, Vera Bittner, Eileen Handberg
European Heart Journal. Quality of Care & Clinical Outcomes. 2026-03-05 - Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies.Christopher S Marnell, Wolfgang Koenig, Vera Bittner, Karol E Watson, Paul Muntner
Circulation. Population Health and Outcomes. 2026-03-02 - 2 citationsOxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome.Sotirios Tsimikas, Michael Szarek, Christa M Cobbaert, Fred Romijn, J Wouter Jukema
Circulation. 2025-12-16
Journal Articles
- Original Investigations Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialVera Bittner, MD, ScienceDirect
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Do Not Smoke, Eat Healthy, and ExerciseVera Bittner, MD, JACC: Cardiovascular Imaging
Lectures
- Lipoprotein(a) Lowering by Alirocumab Contributes to Total Events Reduction Independent of Low-Density Lipoprotein Cholesterol in the ODYSSEY OUTCOMES Trial2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Late-Breaking Clinical Trials2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Hypertension Management Hypercharged: The Devil is in the Details2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Do Not Smoke, Eat Healthy, and ExerciseNovember 2018
- Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United StatesApril 2018
- Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United StatesApril 2018
Press Mentions
UAB Heart Failure Clinic Recognized Nationally for Its ExcellenceOctober 21st, 2025
HRTSA Clinic Recognized NationallyOctober 7th, 2025
UAB Cardiovascular Institute Earns Top Heart Failure Care AwardOctober 6th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









